McKesson has completed an $850 million acquisition of general ophthalmology and retina management services company PRISM Vision Holdings.
Through the acquisition, McKesson will own 80% of PRISM, according to an April 2 news release. PRISM will retain the other 20%.
McKesson will now be able to develop its first retinal and ophthalmology platform, expanding its clinical services and offerings.
The acquisition was first announced in early February.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.